Clinical Trials Browser

NCT06982222 2026-04-13

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Phase 1 Not yet recruiting

24 enrolled

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms

NCT07524322 2026-04-13

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

Phase 1 Not yet recruiting

63 enrolled

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT07383506 2026-03-27

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

Phase 1 Not yet recruiting

90 enrolled

BreastGynecologic

Breast Neoplasms, Endometrial Neoplasms

NCT07310420 2026-03-11

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer

Phase 1 Not yet recruiting

88 enrolled

Breast

Breast Neoplasms

NCT07454668 2026-03-06

Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases

Phase 1 Not yet recruiting

20 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT06251544 2026-03-04

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

Phase 1 Not yet recruiting

27 enrolled

Breast

Breast Neoplasms, Mammary Neoplasms, Animal

NCT07401381 2026-02-10

SIE-1

Phase 1 Not yet recruiting

120 enrolled

Breast

Breast Neoplasms

NCT07387445 2026-02-04

A Multi-site Pilot Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.

Phase 1 Not yet recruiting

40 enrolled

Breast

Intermittent Fasting, Breast Neoplasms, Fasting

NCT07358377 2026-01-22

To Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Subjects With HR-Positive/HER2-Negative Solid Tumor

Phase 1 Not yet recruiting

15 enrolled

Breast

Breast Neoplasms

NCT07320521 2026-01-06

A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects.

Phase 1 Not yet recruiting

6 enrolled

Breast

Breast Neoplasms

NCT07163481 2025-09-16

SoGreat

Phase 1 Not yet recruiting

12 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT07117214 2025-08-12

A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers

Phase 1 Not yet recruiting

36 enrolled

BreastThoracic

Adenocarcinoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT07088588 2025-07-28

Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors

Phase 1 Not yet recruiting

105 enrolled

BreastGynecologic

Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT07036185 2025-06-25

A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors

Phase 1 Not yet recruiting

66 enrolled

BreastGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Bile Duct Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT06948539 2025-04-29

To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors

Phase 1 Not yet recruiting

66 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Colorectal Neoplasms

NCT06619873 2024-10-01

A Phase 1, Randomized, Crossover Study to Evaluate the Relative Bioavailability and Food Effect of HRS-8080 in Healthy Subjects

Phase 1 Not yet recruiting

24 enrolled

Breast

Breast Neoplasms

NCT06614751 2024-09-27

A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway

Phase 1 Not yet recruiting

112 enrolled

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06530082 2024-07-31

A Single Arm Clinical Study of Dendritic Cell Vaccine Loaded With Circular RNA Encoding Cryptic Peptide for Patients With HER2-negative Advanced Breast Cancer

Phase 1 Not yet recruiting

48 enrolled

Breast

Breast Neoplasms